# Levocarnitine

NDC: 0517-1045
Generic name: Levocarnitine
Labeler / Manufacturer: American Regent, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230621

FDA application: ANDA075861

## Active ingredients

- LEVOCARNITINE: 200 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0517-1045"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0517-1045
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc4da2c3-f939-444d-9b5b-a57b6051c190